@johndavis60 I think "4–5 years" (or 3–5) was the standard diagnosis for metastatic prostate cancer based on the SEER database. They told me the same when I was diagnosed in 2021, though they soon backed off.

SEER is necessarily backwards facing, so it hasn't fully caught up with major recent advances in prostate cancer treatment, including new drugs like the -lutamides, and new treatment strategies like doublet/triplet therapy (or even just recognising oligometastatic as a separate category that can be treated with curative rather than just palliative intent).

So "4–5 years" is what @hbp and I might have expected a decade ago, not (necessarily) what we can expect in 2025.